| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
| 2017 | Determination of molecular remission in patients with mycosis fungoides (MF) and Sezary Syndrome (SS) following allogeneic transplant using high throughput sequencing (HTS) | Almazan, T.; Armstrong, R.; Kim, Y. H.; Weng, W. | Journal of Investigative Dermatology | | | |
| 2011 | Efficient and reliable skin responses with unconventional low-dose total skin electron beam therapy in mycosis fungoides: A phase II study | Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Weng, W.; Sundram, U.; Dabaja, B.; Singh, L.; Duvic, M.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | | |
| 2012 | Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | | |
| 2011 | Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Blood | | | |
| 2012 | The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients | Kelly-Sell, M. J.; Kim, Y. H.; Straus, S.; Benoit, B.; Harrison, C.; Sutherland, K.; Armstrong, R.; Wen-Kai Weng ; Showe, L. C.; Wysocka, M.; Rook, A. H. | American Journal of Hematology | | | |
| 2013 | Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Desmarais, C.; Hoppe, R.; Kim, Y. H. | Science Translational Medicine | | | |
| 2014 | Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sezary Syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Johnston, L.; Laport, G. G.; Lowsky, R.; Miklos, D. B.; Shizuru, J. A.; Benjamin, J. E.; Negrin, R. S.; Reddy, S.; Million, L.; Hoppe, R. T.; Kim, Y. H. | Blood | | | |
| 2020 | Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma | Wen-Kai Weng ; Arai, S.; Rezvani, A.; Johnston, L.; Lowsky, R.; Miklos, D.; Shizuru, J.; Muffly, L.; Meyer, E.; Negrin, R. S.; Wang, E.; Almazan, T.; Million, L.; Khodadoust, M.; Li, S. F.; Hoppe, R. T.; Kim, Y. H. | Blood Advances | | | |
| 2015 | Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project | Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; Hoppe, R. T.; Nguyen-Lin, A.; Wen-Kai Weng ; Armstrong, R.; Pulitzer, M.; Advani, R. H.; Horwitz, S. M. | Journal of Clinical Oncology | | | |
| 2018 | Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sezary Syndrome | Dai, J.; Almazan, T. H.; Hong, E. K.; Khodadoust, M. S.; Arai, S.; Wen-Kai Weng ; Kim, Y. H. | Jama Dermatology | | | |
| 2011 | A prospective trial of low-dose total skin electron beam therapy in mycosis fungoides and proposal of a new clinically meaningful endpoint | Bashey, S.; Harrison, C.; Navi, D.; Lingala, B.; Armstrong, R.; Wen-Kai Weng ; Sundram, U.; Kim, Y. H.; Hoppe, R. | Journal Der Deutschen Dermatologischen Gesellschaft | | | |
| 2016 | A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT) | Kim, Y. H.; Hoppe, R. T.; Rook, A. H.; Maity, A.; Geskin, L. J.; Horowitz, D. P.; Finnegan, G.; Khodadoust, M.; Wen-Kai Weng ; Lares, A.; Hong, E. K. J.; Buchanan, M.; Ma, V.; Kha, H.; Lawrence, C. E.; Vainstein, V.; Basile, L. A. | Blood | | | |
| 2012 | Transcriptome sequencing in Sezary Syndrome identifies novel Sezary cell-associated transcripts | Lee, C.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D.; Armstrong, R.; Weng, W.; Aros, C.; Mah, A.; Kretz, M.; Kim, Y. H.; Khavari, P. A. | Journal of Investigative Dermatology | | | |
| 2012 | Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts | Lee, C. S.; Ungewickell, A.; Bhaduri, A.; Qu, K.; Webster, D. E.; Armstrong, R.; Wen-Kai Weng ; Aros, C. J.; Mah, A.; Chen, R. O.; Lin, M. H.; Sundram, U.; Chang, H. Y.; Kretz, M.; Kim, Y. H.; Khavari, P. A. | Blood | | | |
| 2014 | Use of High-Throughput Sequencing (HTS) of TCR beta to Determine the Kinetics of Graft-Versus-Lymphoma (GVL) Effect and T-Cell Repertoire Profiles after Allogeneic Transplant | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Hoppe, R. T.; Meyer, E. H.; Kim, Y. H. | Blood | | | |
| 2014 | Utility of high-throughput sequencing of T cell receptor gene rearrangement to improve diagnosis in cutaneous T cell lymphoma | Rozati, S.; Weng, W.; Tavallaee, M.; Kim, J.; Rieger, K.; Armstrong, R.; Kirsch, I.; Kim, Y. H. | Journal of Investigative Dermatology | | | |
| 2019 | Volumetric Modulated Arc Therapy and 3-Dimensional Printed Bolus in the Treatment of Refractory Primary Cutaneous Gamma Delta Lymphoma of the Bilateral Legs | Obeid, J. P.; Gutkin, P. M.; Lewis, J.; Skinner, L.; Wang, E. B.; Khodadoust, M. S.; Kim, Y. H.; Wen-Kai Weng ; Hoppe, R. T.; Hiniker, S. M. | Practical Radiation Oncology | | | |
